My Baby Biome: Infant Stool Samples for Microbiome Health (MBB)

Persephone Biosciences

Status: Active, not recruiting

Conditions: Dysbiosis

Study type: Observational

Funder types: Industry

Identifiers

NCT05472688

PB-2022-01

Details and patient eligibility

About

My Baby Biome is an observational study that will use 600 infant stool samples to determine the biomarkers associated with a healthy infant gut. Biomarkers identified in this study will be used to develop precision probiotics and LBPs for improving infant gut health outcomes to the benefit of all infants. Parents will be asked to submit follow-up questionnaires regarding infant immune health to improve insights obtained from the data.

Enrollment: 430 patients

Sex: All

Ages: Under 2 months old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Exclusion Criteria:

• Infants under 2 weeks or over 2 months old
• Infants given any antibiotic or probiotic treatments
• Infants delivered prematurely or admitted to the NICU outside of establishment of normal feeding
• Infants with mothers under the age of 18
• Infants with mothers known to have HIV, Hepatitis A, Hepatitis B, Hepatitis C, or SARS-CoV2